AbbVie (ABBV): An Undervalued Dividend Aristocrat
May 25, 2021 at 10:31 AM EDT
AbbVie Inc (ABBV) has an established eight-year track record of producing outstanding returns and superior dividend growth. Strong cash flow will enable ABBV to deleverage the balance sheet and support a growing dividend.
